These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37776338)

  • 1. Ocular drug delivery systems: glaucoma patient perceptions from a German university hospital eye clinic.
    Weber C; Quintin P; Holz FG; Fea A; Mercieca K
    Graefes Arch Clin Exp Ophthalmol; 2024 Feb; 262(2):545-556. PubMed ID: 37776338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Survey on the Preference of Sustained Glaucoma Drug Delivery Systems by Singaporean Chinese Patients: A Comparison Between Subconjunctival, Intracameral, and Punctal Plug Routes.
    Chan HH; Wong TT; Lamoureux E; Perera S
    J Glaucoma; 2015 Sep; 24(7):485-92. PubMed ID: 25580892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Survey on Patients' Opinions of Alternative Drug Delivery Systems for the Treatment of Glaucoma in South-South Nigeria.
    Echieh CI; Mercieca K; Eze UA; Weber C; Akinyemi A; Ibanga AA; Echieh CP
    Middle East Afr J Ophthalmol; 2022; 29(4):220-225. PubMed ID: 38162567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Acceptance of Sustained Glaucoma Treatment Strategies.
    Varadaraj V; Kahook MY; Ramulu PY; Pitha IF
    J Glaucoma; 2018 Apr; 27(4):328-335. PubMed ID: 29462013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance, attitudes, and beliefs of Singaporean Chinese toward an ocular implant for glaucoma drug delivery.
    Foo RC; Lamoureux EL; Wong RC; Ho SW; Chiang PP; Rees G; Aung T; Wong TT
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8240-5. PubMed ID: 23188725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient attitudes toward novel glaucoma drug delivery approaches.
    Wang BB; Lin MM; Nguyen T; Turalba AV
    Digit J Ophthalmol; 2018; 24(2):16-23. PubMed ID: 30800009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
    O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
    Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
    Rees G; Leong O; Crowston JG; Lamoureux EL
    Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release ocular drug delivery systems for glaucoma therapy.
    Al-Qaysi ZK; Beadham IG; Schwikkard SL; Bear JC; Al-Kinani AA; Alany RG
    Expert Opin Drug Deliv; 2023; 20(7):905-919. PubMed ID: 37249548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' and prescribers' perception of contact lenses as a potential ocular drug delivery system.
    Ghazal H; Ahmadouk J; Dhanji S; El-Bushra A; Kayyali R; ElShaer A
    Cont Lens Anterior Eye; 2019 Apr; 42(2):190-195. PubMed ID: 30442512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient acceptance and attitude toward an alternative method of subconjunctival injection for the medical treatment of glaucoma.
    Chong RS; Su DH; Tsai A; Jiang Y; Htoon HM; Lamoureux EL; Aung T; Wong TT
    J Glaucoma; 2013 Mar; 22(3):190-4. PubMed ID: 22036716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of benzalkonium chloride in topical glaucoma treatment: An investigation of the efficacy and safety of benzalkonium chloride-preserved intraocular pressure-lowering eye drops and their effect on conjunctival goblet cells.
    Nagstrup AH
    Acta Ophthalmol; 2023 Dec; 101 Suppl 278():3-21. PubMed ID: 38037546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia.
    Mehari T; Giorgis AT; Shibeshi W
    BMC Ophthalmol; 2016 Aug; 16():131. PubMed ID: 27485739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to glaucoma medication, illness perceptions, and beliefs about glaucoma: Attitudinal perspectives among Turkish population.
    Guven S; Koylu MT; Mumcuoglu T
    Eur J Ophthalmol; 2021 Mar; 31(2):469-476. PubMed ID: 32019338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the number of glaucoma medications, ocular surface disorder, and treatment adherence.
    Samico GA; Abe RY; Prata TS; Teixeira SH; Paranhos A; Gracitelli CPB
    Arq Bras Oftalmol; 2023; 87(6):e20210525. PubMed ID: 37851737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication.
    Salyani A; Birt C
    Can J Ophthalmol; 2005 Apr; 40(2):170-4. PubMed ID: 16049530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan.
    Tsumura T; Kashiwagi K; Suzuki Y; Yoshikawa K; Suzumura H; Maeda T; Takeda R; Saito H; Araie M
    Int Ophthalmol; 2019 Feb; 39(2):375-383. PubMed ID: 29330811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
    Spencer SKR; Shulruf B; McPherson ZE; Zhang H; Lee MB; Francis IC; Bank A; Coroneo MT; Agar A
    Ophthalmol Glaucoma; 2019; 2(2):86-93. PubMed ID: 32672609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
    Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
    Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.